Re:The Pain Hustlers
by mirimir on Thursday May 03, 2018 @02:36AM
(#16983815)
One issue is how drug reps push off-label prescribing. In order to increase sales. That was the core issue with Neuronin (gabapentin), for example.
[ Parent
| on HN ]
Although off-label marketing is inappropriate and possibly illegal, in this case I believe patients probably benefited from it.